Filing of Certificate in terms of Regulation 74(5) of the SEBI (Depositories & Participants) Regulations, 2018 for the quarter and financial year ended March 31, 2025 received from the ....
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India submitted a compliance certificate to BSE for the quarter and financial year ended March 31, 2025, as required under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. The certificate was issued by their Registrar and Share Transfer Agent (RTA) on April 2, 2025. It confirms that all securities received from depository participants for dematerialization during the quarter were duly processed, verified, and listed on the stock exchanges. Security certificates were mutilated and cancelled post-verification, and depository names were updated in the register of members within the prescribed timelines. The filing also informs that the RTA's name has changed from 'Link Intime India Private Limited' to 'MUFG Intime India Private Limited'.
This is a routine regulatory compliance filing with no material impact on the business, operations, or stock price. Shareholders may note the RTA name change from Link Intime to MUFG Intime for any future share-related correspondence.